GLP-1 analogue-Fc fusion protein(Shanghai Hailu)

重组人胰高血糖素样肽-1类似物-Fc融合蛋白（上海海路）

Report date: 2022/11/05 16:05:43

Base Information

Drug NameGLP-1 analogue-Fc fusion protein(Shanghai Hailu)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShanghai Hailu Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Hailu Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A